CCM
ELV icon

Catawba Capital Management’s Elevance Health ELV Stock Holding History

Catawba Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$6.3M Sell
26,462
-184
-0.7% -$42.6K 1.48% 17
2018
Q1 		$5.85M Sell
26,646
-1,943
-7% -$456K 1.4% 21
2017
Q4 		$6.43M Sell
28,589
-2,621
-8% -$558K 1.45% 18
2017
Q3 		$5.93M Sell
31,210
-1,514
-5% -$288K 1.34% 20
2017
Q2 		$6.16M Sell
32,724
-1,636
-5% -$294K 1.4% 17
2017
Q1 		$5.68M Sell
34,360
-2,019
-6% -$321K 1.24% 20
2016
Q4 		$5.23M Sell
36,379
-707
-2% -$94.7K 1.22% 22
2016
Q3 		$4.65M Sell
37,086
-825
-2% -$107K 1.1% 29
2016
Q2 		$4.98M Sell
37,911
-515
-1% -$70.5K 1.21% 24
2016
Q1 		$5.34M Sell
38,426
-815
-2% -$109K 1.36% 17
2015
Q4 		$5.47M Sell
39,241
-2,400
-6% -$331K 1.49% 16
2015
Q3 		$5.83M Sell
41,641
-4,157
-9% -$625K 1.6% 10
2015
Q2 		$7.52M Sell
45,798
-3,118
-6% -$498K 1.79% 6
2015
Q1 		$7.55M Sell
48,916
-220
-0.4% -$31.3K 1.73% 7
2014
Q4 		$6.17M Buy
49,136
+415
+0.9% +$51.3K 1.43% 16
2014
Q3 		$5.83M Sell
48,721
-2,303
-5% -$264K 1.36% 15
2014
Q2 		$5.49M Sell
51,024
-707
-1% -$72.8K 1.24% 24
2014
Q1 		$5.15M Sell
51,731
-535
-1% -$48.4K 1.23% 25
2013
Q4 		$4.83M Buy
52,266
+332
+0.6% +$29.5K 1.16% 28
2013
Q3 		$4.34M Buy
51,934
+1,897
+4% +$163K 1.14% 28
2013
Q2 		$4.09M Buy
+50,037
New +$3.74M 1.14% 30

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Catawba Capital Management's ELV Position: Q2 2018 in Review

Catawba Capital Management reduced its Elevance Health (ELV) stake by 0.69% in Q2 2018, selling an estimated $42.6K and leaving 26,462 shares worth $6.3M. The position accounts for 1.48% of the portfolio, ranked #17.

Catawba Capital Management first reported a position in ELV in Q2 2013 and has held it in 21 quarters since. The position peaked at $7.55M in Q1 2015. 935 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

  • Catawba Capital Management held 26,462 shares of Elevance Health worth $6.3M as of Q2 2018.
  • Catawba Capital Management sold 184 Elevance Health shares in Q2 2018, an estimated $42.6K.
  • Elevance Health made up 1.48% of Catawba Capital Management's portfolio in Q2 2018, its #17 holding.
  • Catawba Capital Management first reported a position in Elevance Health in Q2 2013 and has held it in 21 quarters since.
  • Catawba Capital Management's Elevance Health position peaked at $7.55M in Q1 2015.
  • 935 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Catawba Capital Management's 13F filing for Q2 2018, filed 11 Jul 2018.